Solifenacin Succinate
45 NDCs across 12 manufacturers|42 Generic,3 Brand
Solifenacin Succinate is used to treat overactive urinary bladder and urge urinary incontinence, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 19, 2004, and the first generic was approved Apr 2, 2014. FDA's Orange Book lists 36 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $71 million on Solifenacin Succinate across 1.4 million claims for 394,000 beneficiaries.
Solifenacin Succinate is available as 45 NDCs from 12 manufacturers (42 generic, 3 brand), with NADAC prices from $0.14 to $12.31 per EA — the most expensive product costs about 87× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
45
42G / 3B
Manufacturers
12
competing in market
Price Spread
$0.14 – $12.31
per EA, 44 of 45 NDCs
7d Activity
avg -8.3% WoW · of 45 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Ajanta Pharma USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cholinergic Muscarinic Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
12 manufacturers producing SOLIFENACIN SUCCINATE(2 pricing outliers)
Frequently Asked Questions
What is Solifenacin Succinate used to treat?
Solifenacin Succinate is used to treat overactive urinary bladder and urge urinary incontinence, per the National Library of Medicine's MED-RT classification.
When did Solifenacin Succinate become available as a generic?
FDA approved the first generic Solifenacin Succinate (ANDA) on Apr 2, 2014. The Orange Book currently lists 36 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Solifenacin Succinate?
In 2024, Medicare Part D spent $71 million on Solifenacin Succinate across 1.4 million claims for 394,000 beneficiaries.
How many Solifenacin Succinate products are on the market?
The Solifenacin Succinate drug market contains 45 NDCs from 12 manufacturers — 42 generic and 3 brand products.
What is the price range for Solifenacin Succinate?
NADAC reference prices for Solifenacin Succinate range from $0.1413 to $12.3099 per EA — the most expensive product costs about 87× the cheapest. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Is generic Solifenacin Succinate cheaper than brand?
The average generic NADAC for Solifenacin Succinate is $0.1594 per EA, versus $12.2887 for brand-labeled products — brand versions average about 77× the generic price.
Which manufacturers make Solifenacin Succinate?
12 manufacturers list Solifenacin Succinate in NADAC. Ranked by number of NDCs, the largest are Ajanta Pharma USA Inc. (4), Glenmark Pharmaceuticals Inc., USA (4), Actavis Pharma, Inc. (4), Novadoz Pharmaceuticals LLC (4), Camber Pharmaceuticals Inc. (4).
How has the price of Solifenacin Succinate changed recently?
Over the past 7 days, 0 Solifenacin Succinate NDCs rose and 38 fell, with a market-wide average change of -8.3%.